 Hypertension, Pulmonary
"Hypertension, Pulmonary" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Increased VASCULAR RESISTANCE in the PULMONARY CIRCULATION, usually secondary to HEART DISEASES or LUNG DISEASES.
| Descriptor ID |
D006976
|
| MeSH Number(s) |
C08.381.423
|
| Concept/Terms |
Ayerza Syndrome- Ayerza Syndrome
- Syndrome, Ayerza
- Ayerza's Syndrome
- Ayerzas Syndrome
- Ayerza-Arrilaga Syndrome
- Ayerza Arrilaga Syndrome
- Syndrome, Ayerza-Arrilaga
|
Below are MeSH descriptors whose meaning is more general than "Hypertension, Pulmonary".
Below are MeSH descriptors whose meaning is more specific than "Hypertension, Pulmonary".
This graph shows the total number of publications written about "Hypertension, Pulmonary" by people in this website by year, and whether "Hypertension, Pulmonary" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1980 | 0 | 1 | 1 | | 1983 | 4 | 0 | 4 | | 1984 | 3 | 1 | 4 | | 1985 | 5 | 0 | 5 | | 1986 | 2 | 2 | 4 | | 1987 | 2 | 1 | 3 | | 1988 | 5 | 1 | 6 | | 1989 | 5 | 0 | 5 | | 1990 | 2 | 0 | 2 | | 1991 | 5 | 1 | 6 | | 1992 | 4 | 4 | 8 | | 1993 | 5 | 0 | 5 | | 1994 | 9 | 3 | 12 | | 1995 | 11 | 1 | 12 | | 1996 | 15 | 4 | 19 | | 1997 | 13 | 2 | 15 | | 1998 | 21 | 3 | 24 | | 1999 | 16 | 1 | 17 | | 2000 | 11 | 2 | 13 | | 2001 | 14 | 1 | 15 | | 2002 | 17 | 4 | 21 | | 2003 | 15 | 5 | 20 | | 2004 | 27 | 3 | 30 | | 2005 | 36 | 4 | 40 | | 2006 | 23 | 5 | 28 | | 2007 | 27 | 6 | 33 | | 2008 | 29 | 4 | 33 | | 2009 | 32 | 2 | 34 | | 2010 | 32 | 6 | 38 | | 2011 | 33 | 6 | 39 | | 2012 | 36 | 9 | 45 | | 2013 | 42 | 5 | 47 | | 2014 | 37 | 4 | 41 | | 2015 | 41 | 5 | 46 | | 2016 | 26 | 4 | 30 | | 2017 | 3 | 2 | 5 |
To return to the timeline, click here.
Below are the most recent publications written about "Hypertension, Pulmonary" by people in Profiles.
-
Amsallem M, Sweatt AJ, Aymami MC, Kuznetsova T, Selej M, Lu H, Mercier O, Fadel E, Schnittger I, McConnell MV, Rabinovitch M, Zamanian RT, Haddad F. Right Heart End-Systolic Remodeling Index Strongly Predicts Outcomes in Pulmonary Arterial Hypertension: Comparison With Validated Models. Circ Cardiovasc Imaging. 2017 Jun; 10(6).
-
Mouradian GC, Gaurav R, Pugliese S, El Kasmi K, Hartman B, Hernandez-Lagunas L, Stenmark KR, Bowler RP, Nozik-Grayck E. Superoxide Dismutase 3 R213G Single-Nucleotide Polymorphism Blocks Murine Bleomycin-Induced Fibrosis and Promotes Resolution of Inflammation. Am J Respir Cell Mol Biol. 2017 Mar; 56(3):362-371.
-
Loomis Z, Eigenberger P, Redinius K, Lisk C, Karoor V, Nozik-Grayck E, Ferguson SK, Hassell K, Nuss R, Stenmark K, Buehler P, Irwin DC. Hemoglobin induced cell trauma indirectly influences endothelial TLR9 activity resulting in pulmonary vascular smooth muscle cell activation. PLoS One. 2017; 12(2):e0171219.
-
Schäfer M, Ivy DD, Abman SH, Barker AJ, Browne LP, Fonseca B, Kheyfets V, Hunter KS, Truong U. Apparent Aortic Stiffness in Children With Pulmonary Arterial Hypertension: Existence of Vascular Interdependency? Circ Cardiovasc Imaging. 2017 Feb; 10(2).
-
Zijlstra WM, Elmasry O, Pepplinkhuizen S, Ivy DD, Bonnet D, Luijendijk P, Lévy M, Gavilan JL, Torrent-Vernetta A, Mendoza A, Del Cerro MJ, Moledina S, Berger RM. Pulmonary arterial hypertension in children after neonatal arterial switch operation. Heart. 2017 Aug; 103(16):1244-1249.
-
Tuder RM. Pulmonary vascular remodeling in pulmonary hypertension. Cell Tissue Res. 2017 Mar; 367(3):643-649.
-
Aiello RJ, Bourassa PA, Zhang Q, Dubins J, Goldberg DR, De Lombaert S, Humbert M, Guignabert C, Cavasin MA, McKinsey TA, Paralkar V. Tryptophan hydroxylase 1 Inhibition Impacts Pulmonary Vascular Remodeling in Two Rat Models of Pulmonary Hypertension. J Pharmacol Exp Ther. 2017 Feb; 360(2):267-279.
-
Yang J, Nies MK, Fu Z, Damico R, Korley FK, Hassoun PM, Ivy DD, Austin ED, Everett AD. Hepatoma-derived Growth Factor Predicts Disease Severity and Survival in Pulmonary Arterial Hypertension. Am J Respir Crit Care Med. 2016 Nov 15; 194(10):1264-1272.
-
Yung LM, Nikolic I, Paskin-Flerlage SD, Pearsall RS, Kumar R, Yu PB. A Selective Transforming Growth Factor-ß Ligand Trap Attenuates Pulmonary Hypertension. Am J Respir Crit Care Med. 2016 Nov 01; 194(9):1140-1151.
-
Brown MB, Neves E, Long G, Graber J, Gladish B, Wiseman A, Owens M, Fisher AJ, Presson RG, Petrache I, Kline J, Lahm T. High-intensity interval training, but not continuous training, reverses right ventricular hypertrophy and dysfunction in a rat model of pulmonary hypertension. Am J Physiol Regul Integr Comp Physiol. 2017 Feb 01; 312(2):R197-R210.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|